Subscribe To Our Free Newsletter |
Hot Stocks: Brokerages on Sun Pharma, Poonawalla Fincorp and Greaves Cotton
BofA Securities maintained buy rating on Sun Pharma with a target price of Rs 1030. The stock closed at Rs 879 on 26 August. There is some scepticism in llumya ramp-up despite upside risk, the investment bank said. It is a buy on earnings support from the specialty sector, said the note.